Verrica's Skin Infection Drug Ycanth Gains Approval in Japan

Verrica's drug Ycanth, which treats the common viral skin infection molluscum contagiosum, gained approval in Japan. This key approval immediately triggers a $10 million cash payment to Verrica, boosting their finances and supporting U.S. sales efforts.